Thorp Clay
- SEC CIK
- 0001592380
No open-market purchases or sales filed in the past year.
Current role at each company
- CLSD Clearside Biomedical, Inc.Directoras of Feb 24, 2025
- PHAS PhaseBio Pharmaceuticals IncDirectoras of May 19, 2023
- VIGL Vigil Neuroscience, Inc.Directoras of May 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Thorp Clay as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CLSD Clearside Biomedical, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 (view filing) | Feb 10, 2021 | 677 days | Thorp ClayDirector | SSale | −32.9K | $4.43 | −$145.6K | −0.7%4.95M after | Amended |
| Dec 21, 2022 (view filing) | Dec 21 | Same day | Thorp ClayDirector | PPurchase | +14.0K | $1.02 | +$14.3K | +84.7%30.5K after | |
| Sep 25, 2023 (view filing) | Sep 25 | Same day | Thorp ClayDirector | PPurchase | +10.0K | $0.86 | +$8.60K | +32.8%40.5K after | |
| Feb 24, 2025 (view filing) | Feb 24 | Same day | Thorp ClayDirector | PPurchase | +15.0K | $0.92 | +$13.8K | +9.3%176.1K after |
VIGL Vigil Neuroscience, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 (view filing) | Jan 11 | Same day | Thorp ClayDirector | PPurchase | +265.0K | $14.00 | +$3.71M | +21.1%1.52M after | |
| Mar 28, 2022 (view filing) | Mar 28 | Same day | Thorp ClayDirector | PPurchase | +3.00K | $7.20 | +$21.6K | New position3.00K after | |
| May 17, 2022 (view filing) | May 16-17 | 1 day | Thorp ClayDirector | PPurchase | +36.7K | $2.85 | +$104.4K | +2.4%1.56M after | 2 lots |
PHAS PhaseBio Pharmaceuticals Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 (view filing) | Aug 18 | Same day | Thorp ClayDirector | PPurchase | +10.0K | $3.00 | +$30.0K | +43.6%32.9K after |